Completed
A Phase 1/2 Study of Ramucirumab Plus Nivolumab in Participants With Gastric or GEJ Cancer
NCT02999295
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
- Locations
-
- National Cancer Center Hospital Tokyo, Japan